InsidersTradesSigma
Novartis Stock: price and management transactions · India · SEBI (PIT + SAST)
SEBI:novartis-e322c4·SEBI (PIT + SAST)
Follow the Novartis share price and the full management transaction log of the company, a listed equity based in India. Shares are listed on IN IN, under the authority of SEBI (PIT + SAST). The latest transaction was filed on 6 August 2026 (Disposal). Among the most active insiders: Novartis AG. The full history is openly available.
3
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€126m
2 ops.
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,928 of 28,134 companies
58.8
score / 100
Value35
Quality83
FCF yld1.2%
Earn yld2.4%
EV/EBITDA29.7x
ROE·
Gross mgn44%
Net mgn26%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 August 2026
Declarations3 total
17,450,680 shares-Off MarketSEBI:d7b496067b1c2cd4d50bf36e7a5028462d0f24af
17,450,680 shares-Off MarketSEBI:c3b58fcfeb40b5d2e656fbf4ba099c5321f9e1c6
Canonical exit: 4 Nov 2026 (T+90)
17,450,680 shares@ ₹789.00100.0% of flowEquityOff MarketSEBI:b3a3fcd8a9ea2ee0236962182cc043ba4978b557
3 of 3 declarations
About Novartis
Novartis is a global pharmaceutical company based in Switzerland, focused on the research and development of innovative medicines. It primarily operates in the fields of oncology, neuroscience, and cardiovascular diseases.